Under which program can pharmacies register to furnish and sell up to ten hypodermic syringes without a prescription?

The Expanded Syringe Access Demonstration Program is specifically designed to allow pharmacies to furnish and sell hypodermic syringes without requiring a prescription, up to a limit of ten syringes. This program aims to improve public health by increasing access to sterile syringes and reducing the transmission of bloodborne diseases among individuals who may be at risk for such infections.

Under this program, pharmacies can play a crucial role in harm reduction strategies, which seek to minimize the negative consequences associated with drug use. By providing access to syringes without a prescription, the program enhances public health initiatives and supports safe practices among individuals who use injectable drugs.

Other programs listed do not focus on the provision of syringes in the same way. For instance, the Controlled Substance Registration Program primarily governs the registration of entities dealing with controlled substances, while the Prescription Medication Management Program and Drug Utilization Review Program are more focused on ensuring the safe and effective use of medications rather than the provision of syringes. Therefore, the Expanded Syringe Access Demonstration Program is uniquely qualified to meet the needs outlined in the question.